BIOMAT Database Logo BIOMAT Database Logo

Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. 2011

Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

Androgen receptor (AR) is reactivated in castration-resistant prostate cancer (CRPC) through mechanisms including marked increases in AR gene expression. We identify an enhancer in the AR second intron contributing to increased AR expression at low androgen levels in CRPC. Moreover, at increased androgen levels, the AR binds this site and represses AR gene expression through recruitment of lysine-specific demethylase 1 (LSD1) and H3K4me1,2 demethylation. AR similarly represses expression of multiple genes mediating androgen synthesis, DNA synthesis, and proliferation while stimulating genes mediating lipid and protein biosynthesis. Androgen levels in CRPC appear adequate to stimulate AR activity on enhancer elements, but not suppressor elements, resulting in increased expression of AR and AR repressed genes that contribute to cellular proliferation.

UI MeSH Term Description Entries
D008297 Male Males
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D004742 Enhancer Elements, Genetic Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter. Enhancer Elements,Enhancer Sequences,Element, Enhancer,Element, Genetic Enhancer,Elements, Enhancer,Elements, Genetic Enhancer,Enhancer Element,Enhancer Element, Genetic,Enhancer Sequence,Genetic Enhancer Element,Genetic Enhancer Elements,Sequence, Enhancer,Sequences, Enhancer
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic

Related Publications

Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.
January 2014, Oncogene,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
December 2023, British journal of cancer,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor.
June 2009, Cancer letters,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function.
September 2012, International journal of cancer,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
June 2013, Molecular oncology,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1).
October 2014, The Journal of biological chemistry,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
May 2015, Journal of ovarian research,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2.
June 2009, Cancer research,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Downregulation of lysine-specific demethylase 1 enhances the sensitivity of hormone-sensitive prostate cancer cells to androgen deprivation therapy.
February 2021, Oncology letters,
Changmeng Cai, and Housheng Hansen He, and Sen Chen, and Ilsa Coleman, and Hongyun Wang, and Zi Fang, and Shaoyong Chen, and Peter S Nelson, and X Shirley Liu, and Myles Brown, and Steven P Balk
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
December 2006, Cancer research,
Copied contents to your clipboard!